Back to Results
First PageMeta Content



March 27, 2018 COMDear provider of pharmaceutical services, In recent years lipid lowering treatment has been transformed by the addition of protein convertase subtilisin kexin type 9 (PCSK9) inhibitors. This p
Add to Reading List

Document Date: 2018-04-10 10:57:24


Open Document

File Size: 362,20 KB

Share Result on Facebook